AIM
TARO

Acrospire Investment Management’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Acrospire Investment Management’s Portfolio TARO Stock Details TARO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-200
Closed -$22K – 1542
2017
Q2 		$22K Hold
200
– – 0.02% 1480
2017
Q1 		$23K Sell
200
-900
-82% -$99.6K 0.02% 1552
2016
Q4 		$116K Sell
1,100
-100
-8% -$10.5K 0.05% 815
2016
Q3 		$133K Buy
1,200
+600
+100% +$79.5K 0.09% 344
2016
Q2 		$87K Sell
600
-100
-14% -$14.2K 0.06% 586
2016
Q1 		$100K Buy
+700
New +$99.4K 0.07% 321

Other funds holding TARO

MICM
Matthews International Capital Management San Francisco, California $292M AUM 75.01% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AL
AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return

Acrospire Investment Management's TARO Position: Q3 2017 in Review

Acrospire Investment Management sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q3 2017, closing a stake of 200 shares — an estimated $22K sold.

Acrospire Investment Management first reported a position in TARO in Q1 2016 and held it in 6 quarters. The position peaked at $133K in Q3 2016. 133 funds tracked by Wall St. Rank hold TARO as of Q3 2017.

  • Acrospire Investment Management reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q3 2017 after selling out during the quarter.
  • Acrospire Investment Management sold 200 Taro Pharmaceutical Industries Ltd. shares in Q3 2017, an estimated $22K.
  • Acrospire Investment Management first reported a position in Taro Pharmaceutical Industries Ltd. in Q1 2016 and held it in 6 quarters.
  • Acrospire Investment Management's Taro Pharmaceutical Industries Ltd. position peaked at $133K in Q3 2016.
  • 133 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q3 2017.

Based on Acrospire Investment Management's 13F filing for Q3 2017, filed 26 Oct 2017.